- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Cedric Loiret-Bernal, M.D. to Participate in Panel Discussion on New Models and Markets for Growth
NanoInk, Inc., a Skokie-based company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries, announced today that its Chief Executive Officer, Cedric Loiret-Bernal, M.D. will be a featured guest speaker at the 2007 NanoBusiness Alliance Conference. Dr. Loiret-Bernal will participate in a panel discussion titled "Tools: Seeing New Models and Markets for Growth," beginning at 11:45 a.m. on Monday, April 16.
Held in New York City at the Marriott Marquis, Time Square from April 15 - 17, 2007, the NanoBusiness Alliance Conference will feature presentations by executives in several high-growth areas including clean energy, water filtration, advanced materials, next-generation electronics, medical diagnostics and pharmaceuticals. Presentations will explore a broad range of issues relating to nanotechnology and investing, commercialization, economic development, environmental, health and safety and global opportunities. The conference is expected to attract hundreds of business leaders, investors, venture capitalists, scientists, engineers and government officials.
"Nanotechnology is completely redefining brand protection for the pharmaceutical industry," said Dr. Loiret-Bernal. "My commentary during the conference will provide attendees with a closer look at the innovative solutions NanoInk is providing its pharmaceutical customers to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products."
"NanoInk, which started largely as an enabling tools infrastructure business is a great case study of a company that has been able to move downstream into high margin, high value products to realize its full growth potential," said Sean Murdock, executive director, NanoBusiness Alliance.
About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. With DPN®, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption™ technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, and the University of Illinois at Urbana-Champaign and the Georgia Institute of Technology. For more information on products and services offered by NanoInk, Inc., see www.nanoink.net.
About The NanoBusiness Alliance
The NanoBusiness Alliance is the industry association for the emerging nanotechnology industry. Through its extensive network of leading startups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Alliance shapes nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations. The NanoBusiness Alliance has offices in Chicago, New York, Connecticut and Washington, DC. For more information, visit http://www.nanobusiness.org .
For more information, please click here
Dresner Corporate Services for NanoInk
Dresner Corporate Services for NanoInk
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Doubling down on Schrödinger's cat May 27th, 2016
Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016